Chronic hepatitis C virus infection, a new cardiovascular risk factor?. (30th January 2016)

• Record Type: Journal Article
• Authors: Domont, Fanny; Cacoub, Patrice
• Is Part Of: Liver international. Volume 36:Number 5(2016)
• Page Start: 621
• Page End: 627
• Publication Date: 2016-01-30
• Subjects: cardiovascular risk factor -- extrahepatic manifestations -- HCV -- ischaemic heart diseases -- stroke; Liver -- Periodicals; Liver -- Diseases -- Periodicals; 616.362
• DOI: 10.1111/liv.13064
• Languages: English
• ISSNs: 1478-3223

Abstract

Abstract: Among the large scope of extrahepatic manifestations related to hepatitis C virus (HCV) infection, many studies recently evaluated the frequency and characteristics of cardiovascular involvement. To assess the current published data on HCV infection and cardiovascular diseases. Published studies on cardiovascular disease, i.e. cerebrovascular accident and ischaemic heart disease in subjects with HCV infection were analysed from literature databases. Subjects with HCV chronic infection have an increased prevalence of carotid atherosclerosis and increased intima‐media thickness compared to healthy controls or those with hepatitis B or non‐alcoholic steatohepatitis. Active chronic HCV infection appears as an independent risk factor for ischaemic cerebrovascular accidents. Active chronic HCV infection is associated with increased risk of ischaemic heart disease. In some studies, successful interferon‐based therapy showed a beneficial impact on the cardiovascular risk. The risk of major cardiovascular events is higher in patients with HCV infection compared to controls, independent of the severity of the liver disease or the common cardiovascular risk factors. The beneficial impact of interferon‐based therapy needs to be confirmed with new direct antiviral interferon‐free agents in prospective studies with extended follow‐up